This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AMG 548

Amgen, Inc.

Drug Names(s): AMG-548

Description: AMG548 is an anti-inflammatory compound whose most clinically relevant translational finding is its ability to inhibit TNF production.

AMG 548 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug